Biotech Catalyst Calendar 2026
A practical conference map for biotech traders, researchers, and catalyst hunters. These are the major 2026 meetings most likely to influence attention, abstract-driven speculation, partnering chatter, and sector-wide momentum.
Why biotech may “wake up” in waves
April to June
This is the strongest near-term cluster for oncology and broader biotech attention: AACR, ASCO, Jefferies, EHA, and BIO all arrive in a fairly tight sequence.
October to December
ESMO, SITC, and ASH often create another meaningful cycle of readouts, poster interest, hematology attention, and late-year speculation.
Not one event — a sequence
The sector rarely wakes up all at once. It usually strengthens as multiple meetings, abstracts, analyst notes, financings, and partnering headlines begin to reinforce one another.
2026 conference schedule
🤝 BIO-Europe Spring 2026
One of the first major spring partnering checkpoints. Good for licensing chatter, business-development signals, and early sentiment shifts.
🧬 AACR Annual Meeting 2026
A major early-year oncology catalyst. Smaller names can get attention from posters, translational science, and first looks at emerging mechanisms.
🎤 ASCO Annual Meeting 2026
ASCO is one of the biggest oncology attention clusters of the year. Headlines, abstracts, investor notes, and sentiment can all compound around this meeting.
🏦 Jefferies Global Healthcare Conference
Important for management commentary, company slides, Q&A snippets, and investor framing across biotech, medtech, pharma, and life-science tools.
🩸 EHA2026 Congress
A key meeting for hematology names. Useful for leukemia, lymphoma, myeloma, MDS, MPN, and other blood-disorder developments.
🌎 BIO International Convention 2026
This is broad biotech rather than a pure clinical-data conference. Still, it can influence sentiment through deal announcements, partnering expectations, and ecosystem visibility.
🧫 ESMO Congress 2026
One of the major fall oncology catalysts. Often important for later-stage cancer programs and large attention spikes heading into year-end.
🛡️ SITC 2026
A focused immunotherapy conference that can matter a great deal for names tied to T-cell, IO combinations, and tumor-immunity narratives.
🧪 ASH Annual Meeting 2026
ASH is one of the most powerful late-year catalyst windows for blood-cancer and hematology names. It often helps define how biotech finishes the year.
How ScanScor can use this calendar
- Watch abstract release dates and company presentation schedules.
- Track financing risk ahead of binary readouts.
- Look for conference, webcast, fireside chat, and poster headlines.
- Compare primary-source company releases against media rewrites.
- Favor original data-heavy stories over wrapper pages and echoes.
- Use NDAPR on usable, material updates — not on every noisy repost.
- Study which names held gains versus faded.
- Track follow-on offerings, analyst notes, and FDA-path commentary.
- Measure whether the conference created a true thesis upgrade.